Pharmacokinetic interactions of psychotropic medications in patients with schizophrenia suffering from atypical mycobacterial infections
| Autor: | D. Palao Vidal, Armand Guàrdia, Javier Labad, A. Alvarez Pedrero, Alexandre González-Rodríguez, M. Betriu Sabaté, José Antonio Monreal, S. Acebillo, E. Pérez-Macho |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Olanzapine
Mycobacterium kansasii medicine.medical_specialty education.field_of_study Tuberculosis Risperidone biology business.industry Population biology.organism_classification medicine.disease Mycobacterium tuberculosis Psychiatry and Mental health Internal medicine Medicine business education Clozapine Rifampicin medicine.drug |
| Zdroj: | European Psychiatry. 64:S649-S650 |
| ISSN: | 1778-3585 0924-9338 |
| Popis: | IntroductionMycobacterium kansasii is a nontuberculous mycobacterium that causes infection associated with past or current tuberculosis disease. Clinical syndromes and radiological findings are mostly indistinguishable from that of Mycobacterium tuberculosis, thus requiring microbiological confirmation.ObjectivesWe report a case of a 44-year-old man diagnosed with schizophrenia and Mycobacterium kansasii infection.MethodsCase report and non-systematic narrative review from PubMed.ResultsCase report: Patient with schizophrenia who was admitted at the inpatient unit presenting psychotic exacerbation with high levels of excitement. Risperidone 6 mg/day and valproate 500 mg/day were initiated. He was also diagnosed with a M. kansasii lung infection, with radiological findings of past tuberculosis disease. Before the microbiological confirmation, it was necessary to start rifampicin, requiring an increase in doses of both psychotropic drugs. Review: (1)Comorbidity of mycobacterial infections and schizophrenia. Several studies have shown that people with severe mental illness have higher rates of tuberculosis compared with the general population. Although the relationship between tuberculosis and M. Kansasii infection is known, few literature is available with regard to the association of M. Kansasii and schizophrenia. (2)Interactions between antipsychotics and mood stabilizers with rifampicin. Rifampicin is mainly metabolized by CYP3A4 and transported by P-glycoprotein. Add-on with rifampicin have been reported to reduce clozapine and olanzapine plasma levels (despite both are metabolized by CYP1A2), reduce haloperidol and risperidone levels (possible role of P-glycoprotein in this interaction), as well as for valproate.ConclusionsTreatment of comorbid infections in people with schizophrenia remains a challenge. Antibiotics used to treat mycobacterial infections can modify the pharmacokinetic of psychotropic drugs.DisclosureNo significant relationships. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|